Company Filing History:
Years Active: 2003
Title: Thomas S Kilduff: Innovator in Hypothalamic Research
Introduction
Thomas S Kilduff is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of neuroscience, particularly in understanding the role of hypothalamic-specific polypeptides in appetite and feeding behavior. His innovative work has implications for therapeutic approaches to obesity and related disorders.
Latest Patents
Kilduff holds a patent for "Hypothalamus-specific polypeptides." This patent discloses hypocretin polynucleotides and hypocretin polypeptides, along with antibodies, oligonucleotides, diagnostic kits, and methods, as well as therapeutic compositions and methods. Hypocretin, a novel hypothalamic-specific polypeptide, is localized to regions of the hypothalamus that are involved in appetite regulation. The biologically active hypocretin polypeptides produce electrical changes in neurons, lower body temperature, and reduce food intake, showcasing their potential in medical applications.
Career Highlights
Kilduff is affiliated with The Scripps Research Institute, where he continues to advance research in his field. His work has garnered attention for its innovative approach to understanding the mechanisms of appetite control and the biological functions of hypothalamic peptides.
Collaborations
Some of Kilduff's notable coworkers include J Gregor Sutcliffe and Kaare M Gautvik. Their collaborative efforts contribute to the ongoing research and development in the field of neuroscience.
Conclusion
Thomas S Kilduff's contributions to the understanding of hypothalamic-specific polypeptides highlight the importance of innovation in neuroscience. His work not only advances scientific knowledge but also opens new avenues for therapeutic interventions in appetite regulation.